Martin Reck
@MartinReck2
Working on medicine
ID:1143791772738433024
26-06-2019 08:03:04
796 Tweets
1,2K Followers
226 Following
Follow People
🔥🚨OncoAlert Hot Off the Press
BIG NEWS Press Release by AstraZeneca
#ADRIATIC phase 3 trial of #Durvalumab vs #Placebo after concurrent chemoradiotherapy
in pts with limited-stage #SmallCell #LungCancer met dual primary endpoints of ⬆️ #OS & ⬆️ #PFS
👇🏼
astrazeneca.com/media-centre/p…
Just released - thank you for a great cooperation!
Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations medscape.org/viewarticle/10… via Medscape Education Eric Lim Ben Solomon @Medscape
Leaving @myesmo IASLC #Prague with a full heart- so amazing to see old friends & new and hear advances in #LungCancer ! #ELCC24
Daniel Tan Anne Tsao, MD, MBA Jhanelle Gray MD Karen Reckamp, MD, MS Joe Y Chang Penn Cancer Innovation Abramson Cancer Ctr.
A wonderful #ELCC24 - congratulations to ESMO - Eur. Oncology and IASLC and looking forward to the next conference to connect with more dear friends and to make new connections! #ESMOAmbassadors
Alona Zer RambamHCC Marco Tagliamento Gustave Roussy The #ELCC24 session titled 'IO therapies: Beyond checkpoint inhibitors,' features:
⭐ Martin Reck of LungenClinic Grosshansdorf
⭐ Dr. Daniel Shao Weng Tan of National Cancer Centre Singapore
⭐ Dr. Michal Lotem of Hadassah Ein Kerem
⭐ Marco Tagliamento of Gustave Roussy
Day 2 at #ELCC24 . Join us today at the Educational Session on novel IO therapies beyond checkpoint inhibitors!
11:15h Congress Hall
Alona Zer Martin Reck Daniel Tan #MichalLotem OncoAlert Università di Genova ESMO - Eur. Oncology
Superb to see this new ESMO - Eur. Oncology living guideline update in non-oncogene addicted metastatic NSCLC published. Great job authors Lizza Hendriks Martin Reck
Just out 📢 The new ESMO Living Guideline on Non-Oncogene-Addicted Metastatic Non-Small-Cell #LungCancer . Updated treatment algorithms & recommendations, directly linked to ESMO-MCBS scores & references, easily accessible on desktop & mobile devices. ow.ly/fTm250QWY2i…
🎥 #JSMO2024 APAC🤝日本臨床腫瘍学会(JSMO)
🎯Education for Oncologists
🎖️Chair Josep Tabernero Prof. Nakajima
✅Clinical trials🎙️Prof. Myung-Ju Ahn
✅Manuscript submission🎙️Herbert Loong
✅JSMO🎙️Dr.Eiji Iwama
✅RISA🎙️Dr.Kazuki Sudo
🗓️Feb23, 9:50AM
🎟️REGISTER
congre.co.jp/jsmo2024/en/re…
OncoAlert
🎥 #JSMO2024 APAC Educational Initiatives
🎖️Chair Prof.Kinoshita Hidehito HORINOUCHI
🔥Get ready after Pre-Meeting
✅Medical Oncology Group of Australia🎙️Melissa Eastgate
✅KSMO🎙️Prof.Yeon Hee Park
✅Singapore Society of Oncology🎙️Dr.Eileen Poon
✅TOS🎙️Prof.Chiun Hsu
🗓️Feb23, 8:20AM
🎟️REGISTER
congre.co.jp/jsmo2024/en/re…
OncoAlert
🎥 #JSMO2024 ASCO🤝日本臨床腫瘍学会(JSMO)
🎯Drugging the Undruggable
🎖️Chair Lynn Schuchter Prof. Ishioka
✅KRAS🎙️Prof. Pasi Janne
✅TP53🎙️Prof. Lipika Goyal
✅Drug develop🎙️Dr. Noboru Yamamoto
✅Wnt/β-catenin🎙️Dr. Yusuke Adachi
🗓️Feb23, 3PM
🎟️REGISTER
congre.co.jp/jsmo2024/en/re…
OncoAlert
We are indebted to the patients who participate in our clinical trials and hope this drives the science forward. A fantastic collaboration with our many internal and external co-authors Stephen V Liu, MD Martin Reck Namrata S Patil Romain Banchereau Lauren Averett Byers, MD Joseph Minhow Chan, MD, PhD Charlie Rudin 4/6